Connect Biopharma Holdings Stock Price on September 11, 2024
| CNTB Stock | USD 1.11 0.03 2.78% |
If you're considering investing in Connect Stock, it is important to understand the factors that can impact its price. As of today, the current price of Connect Biopharma stands at 1.11, as last reported on the 4th of December, with the highest price reaching 1.12 and the lowest price hitting 0.98 during the day. At this point, Connect Biopharma is very risky. Connect Biopharma secures Sharpe Ratio (or Efficiency) of 0.0014, which signifies that the company had a 0.0014% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Connect Biopharma Holdings, which you can use to evaluate the volatility of the firm. Please confirm Connect Biopharma's Standard Deviation of 5.43, risk adjusted performance of (0.05), and Mean Deviation of 3.93 to double-check if the risk estimate we provide is consistent with the expected return of 0.0068%.
At present, Connect Biopharma's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 10.1 K, whereas Common Stock Shares Outstanding is forecasted to decline to about 43.5 M. . At present, Connect Biopharma's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.01, whereas Price Earnings Ratio is forecasted to decline to (1.15). Connect Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Connect |
Sharpe Ratio = 0.0014
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CNTB |
Estimated Market Risk
| 4.86 actual daily | 43 57% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Connect Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Connect Biopharma by adding Connect Biopharma to a well-diversified portfolio.
Price Book 0.5376 | Enterprise Value Ebitda 0.1857 | Price Sales 2.5317 | Shares Float 14.8 M | Wall Street Target Price 7 |
Connect Biopharma Valuation on September 11, 2024
It is possible to determine the worth of Connect Biopharma on a given historical date. On September 11, 2024 Connect was worth 1.23 at the beginning of the trading date compared to the closed value of 1.26. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Connect Biopharma stock. Still, in general, we apply an absolute valuation method to find Connect Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Connect Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Connect Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 1.25 | 1.30 | 1.13 | 1.27 | 24,026 | |
09/11/2024 | 1.23 | 1.27 | 1.23 | 1.26 | 5,172 |
| 1.15 | 1.26 | 1.15 | 1.20 | 7,076 |
| Backtest Connect Biopharma | | | Connect Biopharma History | | | Connect Biopharma Valuation | Previous | Next |
Connect Biopharma Trading Date Momentum on September 11, 2024
| On September 12 2024 Connect Biopharma Holdings was traded for 1.20 at the closing time. The top price for the day was 1.26 and the lowest listed price was 1.15 . The trading volume for the day was 7.1 K. The trading history from September 12, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 4.76% . The overall trading delta against the current closing price is 4.76% . |
Connect Biopharma Fundamentals Correlations and Trends
By evaluating Connect Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Connect Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Connect financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Connect Biopharma Stock history
Connect Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Connect is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Connect Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Connect Biopharma stock prices may prove useful in developing a viable investing in Connect Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 55.1 M | 43.5 M | |
| Net Loss | -1.2 B | -1.1 B |
Connect Biopharma Quarterly Net Working Capital |
|
Connect Biopharma Stock Technical Analysis
Connect Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Connect Biopharma Period Price Range
Low | December 4, 2024
| High |
0.00 | 0.00 |
Connect Biopharma Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Connect Biopharma December 4, 2024 Market Strength
Market strength indicators help investors to evaluate how Connect Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Connect Biopharma shares will generate the highest return on investment. By undertsting and applying Connect Biopharma stock market strength indicators, traders can identify Connect Biopharma Holdings entry and exit signals to maximize returns
Connect Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Connect Biopharma's price direction in advance. Along with the technical and fundamental analysis of Connect Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Connect to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (1.15) | |||
| Treynor Ratio | (0.33) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Connect Stock analysis
When running Connect Biopharma's price analysis, check to measure Connect Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Connect Biopharma is operating at the current time. Most of Connect Biopharma's value examination focuses on studying past and present price action to predict the probability of Connect Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Connect Biopharma's price. Additionally, you may evaluate how the addition of Connect Biopharma to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |